Case 14-2008: A 78-year-old man with anergia and anhedonia associated with cardiovascular surgery

New England Journal of Medicine

Volumn 358, Issue 19, 2008, Pages 2051-

  Huffman, Jeffery C ^a,b   Park, Lawrence T ^a,b   Welch, Charles A ^a,b   Nierenberg, Andrew A ^a,b   Januzzi Jr , James L ^a,b   Pomerantz, Stuart R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARVEDILOL; CITALOPRAM; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; EZETIMIBE; FENOFIBRATE; FLUOXETINE; FOLIC ACID; GLYCERYL TRINITRATE; LITHIUM CARBONATE; LORAZEPAM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MULTIVITAMIN; OLANZAPINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; SPIRONOLACTONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ABDOMINAL AORTA ANEURYSM; AGED; AGITATION; ANERGY; ANHEDONIA; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; BEHAVIOR THERAPY; CARDIOVASCULAR SURGERY; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; HUMAN; IMPULSIVENESS; IRRITABILITY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; PARANOIA; PRIORITY JOURNAL; PSYCHOTHERAPY; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION; CLINICAL OBSERVATION; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIAGNOSIS; FATIGUE; HEART BLOCK; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT;

AGED; ANTIDEPRESSIVE AGENTS; AORTIC ANEURYSM, ABDOMINAL; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; ELECTROCONVULSIVE THERAPY; FATIGUE; HEART BLOCK; HUMANS; MALE; PSYCHOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43249100775     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0801779     Document Type: Article

References (26)

1. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, DC: American Psychiatric Association, 1994:340-7.
2. GS Alexopoulos BS Meyers RC Young T Kakuma D Silbersweig M Charlson Clinically defined vascular depression. Am J Psychiatry 154 1997 562 565
3. GS Alexopoulos DN Kiosses S Klimstra B Kalayam ML Bruce Clinical presentation of the “depression-executive dysfunction syndrome” of late life. Am J Geriatr Psychiatry 10 2002 98 106
4. J O’Brien D Ames E Chiu I Schweitzer P Desmond B Tress Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. Bmj 317 1998 982 984
5. B Rudisch CB Nemeroff Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54 2003 227 240
6. T Rutledge VA Reis SE Linke BH Greenberg PJ Mills Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48 2006 1527 1537
7. I Connerney PA Shapiro JS McLaughlin E Bagiella RP Sloan Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 358 2001 1766 1771
8. RJ Anderson KE Freedland RE Clouse PJ Lustman The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 2001 1069 1078
9. TA Spijkerman RH van den Brink JH Jansen HJ Crijns J Ormel Who is at risk of post-MI depressive symptoms? J Psychosom Res 58 2005 425 432
10. MB Gonzalez TB Snyderman JT Colket Depression in patients with coronary artery disease. Depression 4 1996 57 62
11. RM Carney KE Freedland Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 54 2003 241 247
12. J Barth M Schumacher C Herrmann-Lingen Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66 2004 802 813
13. JA Blumenthal HS Lett MA Babyak Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 2003 604 609
14. RC Ziegelstein JA Fauerbach SS Stevens J Romanelli DP Richter DE Bush Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 160 2000 1818 1823
15. JA Skala KE Freedland RM Carney Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 51 2006 738 745
16. K Kroenke RL Spitzer JB Williams The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 2001 606 613
17. HW Cohen G Gibson MH Alderman Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 108 2000 2 8
18. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79. [Erratum, JAMA 2007;298:40.]
19. LF Berkman J Blumenthal M Burg Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. Jama 289 2003 3106 3116
20. FE Taragano P Bagnatti RF Allegri A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. Int Psychogeriatr 17 2005 487 498
21. CB Taylor ME Youngblood D Catellier Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62 2005 792 798
22. AJ Rush STAR*D: what have we learned? Am J Psychiatry 164 2007 201 204
23. SH Lisanby Electroconvulsive therapy for depression. N Engl J Med 357 2007 1939 1945
24. MM Husain AJ Rush M Fink Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 65 2004 485 491
25. L Bocchio-Chiavetto R Zanardini M Bortolomasi Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 16 2006 620 624
26. G Sanacora GF Mason DL Rothman Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160 2003 577 579